These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 7699005

  • 1. The effects of selective inhibitors of matrix metalloproteinases (MMPs) on bone resorption and the identification of MMPs and TIMP-1 in isolated osteoclasts.
    Hill PA, Murphy G, Docherty AJ, Hembry RM, Millican TA, Reynolds JJ, Meikle MC.
    J Cell Sci; 1994 Nov; 107 ( Pt 11)():3055-64. PubMed ID: 7699005
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of bone resorption in vitro by selective inhibitors of gelatinase and collagenase.
    Hill PA, Docherty AJ, Bottomley KM, O'Connell JP, Morphy JR, Reynolds JJ, Meikle MC.
    Biochem J; 1995 May 15; 308 ( Pt 1)(Pt 1):167-75. PubMed ID: 7755562
    [Abstract] [Full Text] [Related]

  • 3. Functional heterogeneity of osteoclasts: matrix metalloproteinases participate in osteoclastic resorption of calvarial bone but not in resorption of long bone.
    Everts V, Korper W, Jansen DC, Steinfort J, Lammerse I, Heera S, Docherty AJ, Beertsen W.
    FASEB J; 1999 Jul 15; 13(10):1219-30. PubMed ID: 10385612
    [Abstract] [Full Text] [Related]

  • 4. The cellular actions of interleukin-11 on bone resorption in vitro.
    Hill PA, Tumber A, Papaioannou S, Meikle MC.
    Endocrinology; 1998 Apr 15; 139(4):1564-72. PubMed ID: 9528935
    [Abstract] [Full Text] [Related]

  • 5. Human osteoblasts in culture synthesize collagenase and other matrix metalloproteinases in response to osteotropic hormones and cytokines.
    Meikle MC, Bord S, Hembry RM, Compston J, Croucher PI, Reynolds JJ.
    J Cell Sci; 1992 Dec 15; 103 ( Pt 4)():1093-9. PubMed ID: 1336777
    [Abstract] [Full Text] [Related]

  • 6. The effects of serine proteinase inhibitors on bone resorption in vitro.
    Tumber A, Papaioannou S, Breckon J, Meikle MC, Reynolds JJ, Hill PA.
    J Endocrinol; 2003 Sep 15; 178(3):437-47. PubMed ID: 12967336
    [Abstract] [Full Text] [Related]

  • 7. EGF and IL-1 alpha modulate the release of collagenase, gelatinase and TIMP-1 as well as the release of calcium by rabbit calvarial bone explants.
    van der Zee E, Jansen I, Hoeben K, Beertsen W, Everts V.
    J Periodontal Res; 1998 Jan 15; 33(1):65-72. PubMed ID: 9524323
    [Abstract] [Full Text] [Related]

  • 8. Tissue inhibitor of metalloproteinases 1 and 2 directly stimulate the bone-resorbing activity of isolated mature osteoclasts.
    Sobue T, Hakeda Y, Kobayashi Y, Hayakawa H, Yamashita K, Aoki T, Kumegawa M, Noguchi T, Hayakawa T.
    J Bone Miner Res; 2001 Dec 15; 16(12):2205-14. PubMed ID: 11760833
    [Abstract] [Full Text] [Related]

  • 9. Regulation of matrix metalloproteinases (MMP-2, -3, -9, and -13) by interleukin-1 and interleukin-6 in mouse calvaria: association of MMP induction with bone resorption.
    Kusano K, Miyaura C, Inada M, Tamura T, Ito A, Nagase H, Kamoi K, Suda T.
    Endocrinology; 1998 Mar 15; 139(3):1338-45. PubMed ID: 9492070
    [Abstract] [Full Text] [Related]

  • 10. Osteoclastic bone degradation and the role of different cysteine proteinases and matrix metalloproteinases: differences between calvaria and long bone.
    Everts V, Korper W, Hoeben KA, Jansen ID, Bromme D, Cleutjens KB, Heeneman S, Peters C, Reinheckel T, Saftig P, Beertsen W.
    J Bone Miner Res; 2006 Sep 15; 21(9):1399-408. PubMed ID: 16939398
    [Abstract] [Full Text] [Related]

  • 11. Distribution of matrix metalloproteinases and their inhibitor, TIMP-1, in developing human osteophytic bone.
    Bord S, Horner A, Hembry RM, Reynolds JJ, Compston JE.
    J Anat; 1997 Jul 15; 191 ( Pt 1)(Pt 1):39-48. PubMed ID: 9279657
    [Abstract] [Full Text] [Related]

  • 12. The release of tissue inhibitor of metalloproteinases by calvarial bone explants and its immunolocalization.
    Everts V, Hoeben K, Beertsen W.
    Bone Miner; 1993 Jul 15; 22(1):43-55. PubMed ID: 8219937
    [Abstract] [Full Text] [Related]

  • 13. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
    Nakano A, Tani E, Miyazaki K, Yamamoto Y, Furuyama J.
    J Neurosurg; 1995 Aug 15; 83(2):298-307. PubMed ID: 7616276
    [Abstract] [Full Text] [Related]

  • 14. Degradation of collagen in the bone-resorbing compartment underlying the osteoclast involves both cysteine-proteinases and matrix metalloproteinases.
    Everts V, Delaissé JM, Korper W, Niehof A, Vaes G, Beertsen W.
    J Cell Physiol; 1992 Feb 15; 150(2):221-31. PubMed ID: 1734028
    [Abstract] [Full Text] [Related]

  • 15. Type I collagen degradation by mouse calvarial osteoblasts stimulated with 1,25-dihydroxyvitamin D-3: evidence for a plasminogen-plasmin-metalloproteinase activation cascade.
    Thomson BM, Atkinson SJ, McGarrity AM, Hembry RM, Reynolds JJ, Meikle MC.
    Biochim Biophys Acta; 1989 Nov 20; 1014(2):125-32. PubMed ID: 2554972
    [Abstract] [Full Text] [Related]

  • 16. Chondrocyte cultures express matrix metalloproteinase mRNA and immunoreactive protein; stromelysin-1 and 72 kDa gelatinase are localized in extracellular matrix vesicles.
    Schmitz JP, Dean DD, Schwartz Z, Cochran DL, Grant GM, Klebe RJ, Nakaya H, Boyan BD.
    J Cell Biochem; 1996 Jun 01; 61(3):375-91. PubMed ID: 8761942
    [Abstract] [Full Text] [Related]

  • 17. Production of matrix metalloproteinases at the bone-implant interface in loose total hip replacements.
    Yokohama Y, Matsumoto T, Hirakawa M, Kuroki Y, Fujimoto N, Imai K, Okada Y.
    Lab Invest; 1995 Dec 01; 73(6):899-911. PubMed ID: 8558853
    [Abstract] [Full Text] [Related]

  • 18. Matrix metalloproteinases in periodontal tissue remodelling.
    Sodek J, Overall CM.
    Matrix Suppl; 1992 Dec 01; 1():352-62. PubMed ID: 1480060
    [Abstract] [Full Text] [Related]

  • 19. Cysteine proteinases and matrix metalloproteinases play distinct roles in the subosteoclastic resorption zone.
    Everts V, Delaissé JM, Korper W, Beertsen W.
    J Bone Miner Res; 1998 Sep 01; 13(9):1420-30. PubMed ID: 9738514
    [Abstract] [Full Text] [Related]

  • 20. Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function.
    Hill PA, Reynolds JJ, Meikle MC.
    Endocrinology; 1995 Jan 01; 136(1):124-31. PubMed ID: 7828521
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.